143 related articles for article (PubMed ID: 19286195)
41. Controlled trial of thyrotropin releasing hormone tartrate in ataxia of spinocerebellar degenerations.
Sobue I; Takayanagi T; Nakanishi T; Tsubaki T; Uono M; Kinoshita M; Igata A; Miyazaki M; Yoshida M; Ando K
J Neurol Sci; 1983 Oct; 61(2):235-48. PubMed ID: 6417282
[TBL] [Abstract][Full Text] [Related]
42. Cerebral blood flow in spinocerebellar degenerations: a single photon emission tomography study in 28 patients.
De Michele G; Mainenti PP; Soricelli A; Di Salle F; Salvatore E; Longobardi MR; Postiglione A; Salvatore M; Filla A
J Neurol; 1998 Sep; 245(9):603-8. PubMed ID: 9758299
[TBL] [Abstract][Full Text] [Related]
43. Altered cerebral blood flow in patients with spinocerebellar degeneration.
Liu B; Yang A; Gao W; Chen Y; Wang Y; Liu X; Lv K; Zhang L; Ma G
Front Neurosci; 2022; 16():977145. PubMed ID: 36177360
[TBL] [Abstract][Full Text] [Related]
44. [Abnormally distributed regional cerebral blood flow in brain malformations detected by single photon emission computed tomography].
Ueda M; Kamiya T; Sakamoto S; Katayama Y; Terashi A
Rinsho Shinkeigaku; 1997 Feb; 37(2):99-105. PubMed ID: 9164139
[TBL] [Abstract][Full Text] [Related]
45. Statistical parametric mapping analysis of the relationship between regional cerebral blood flow and symptom clusters of the depressive mood in patients with pre-dialytic chronic kidney disease.
Kim SJ; Song SH; Kim JH; Kwak IS
Ann Nucl Med; 2008 Apr; 22(3):201-6. PubMed ID: 18498035
[TBL] [Abstract][Full Text] [Related]
46. Acute and chronic effects of thyrotropin-releasing hormone (TRH) on stabilogram in spinocerebellar degenerations.
Yoshida M; Nakanishi T; Komatsu Y
Tohoku J Exp Med; 1986 Mar; 148(3):327-31. PubMed ID: 3085285
[TBL] [Abstract][Full Text] [Related]
47. PET study in a patient with spinocerebellar degeneration before and after long-term administration of thyrotropin releasing hormone.
Tanji H; Nagasawa H; Hayashi T; Onodera H; Fujiwara T; Itoh M; Ido T; Itoyama Y
Behav Neurol; 1996; 9(3):171-5. PubMed ID: 24487517
[TBL] [Abstract][Full Text] [Related]
48. Relationship between vasodilatation and cerebral blood flow increase in impaired hemodynamics: a PET study with the acetazolamide test in cerebrovascular disease.
Okazawa H; Yamauchi H; Toyoda H; Sugimoto K; Fujibayashi Y; Yonekura Y
J Nucl Med; 2003 Dec; 44(12):1875-83. PubMed ID: 14660711
[TBL] [Abstract][Full Text] [Related]
49. P300 and cerebral blood flow before and after TRH in olivopontocerebellar atrophy.
Mochizuki Y; Oishi M; Hara M; Takasu T
Int J Neurosci; 1997 Nov; 92(1-2):119-26. PubMed ID: 9522261
[TBL] [Abstract][Full Text] [Related]
50. Thyrotropin-releasing hormone (TRH) causes sympathetic activation and cerebral vasodilation in the rabbit.
Koskinen LO; Bill A
Acta Physiol Scand; 1984 Oct; 122(2):127-36. PubMed ID: 6097095
[TBL] [Abstract][Full Text] [Related]
51. Effect of thyrotropin-releasing hormone on cerebral blood flow in conscious rat.
Kondoh Y; Mizusawa S; Murakami M; Nagata K; Sasaki H; Nakamichi H; Watanabe K; Uemura K
J Cereb Blood Flow Metab; 1989 Apr; 9(2):196-203. PubMed ID: 2493461
[TBL] [Abstract][Full Text] [Related]
52. Three brain SPECT region-of-interest templates in elderly people: normative values, hemispheric asymmetries, and a comparison of single- and multihead cameras.
Lobaugh NJ; Caldwell CB; Black SE; Leibovitch FS; Swartz RH
J Nucl Med; 2000 Jan; 41(1):45-56. PubMed ID: 10647604
[TBL] [Abstract][Full Text] [Related]
53. Evaluation of brain perfusion SPECT using an easy Z-score imaging system (eZIS) as an adjunct to early-diagnosis of neurodegenerative diseases.
Waragai M; Yamada T; Matsuda H
J Neurol Sci; 2007 Sep; 260(1-2):57-64. PubMed ID: 17493637
[TBL] [Abstract][Full Text] [Related]
54. The short-term effect of acetylcholinesterase inhibitor on the regional cerebral blood flow of Alzheimer's disease.
Cho H; Kwon JH; Seo HJ; Kim JS
Arch Gerontol Geriatr; 2010; 50(2):222-6. PubMed ID: 19398134
[TBL] [Abstract][Full Text] [Related]
55. Adrenergic and non-adrenergic cardiovascular effects of thyrotropin-releasing hormone (TRH) in the anaesthetized rabbit.
Seligsohn EE
Acta Physiol Scand; 1992 Sep; 146(1):107-17. PubMed ID: 1359733
[TBL] [Abstract][Full Text] [Related]
56. Changes in regional cerebral blood flow caused by deep-brain stimulation of the subthalamic nucleus in Parkinson's disease.
Sestini S; Scotto di Luzio A; Ammannati F; De Cristofaro MT; Passeri A; Martini S; Pupi A
J Nucl Med; 2002 Jun; 43(6):725-32. PubMed ID: 12050315
[TBL] [Abstract][Full Text] [Related]
57. Fully automated quantification of regional cerebral blood flow with three-dimensional stereotaxic region of interest template: validation using magnetic resonance imaging--technical note.
Takeuchi R; Yonekura Y; Takeda SK; Fujita K; Konishi J
Neurol Med Chir (Tokyo); 2003 Mar; 43(3):153-62. PubMed ID: 12699126
[TBL] [Abstract][Full Text] [Related]
58. Fully automatic input function determination program for simple noninvasive (123)I-IMP microsphere cerebral blood flow quantification method.
Yamashita K; Uchiyama Y; Ofuji A; Mimura H; Okumiya S; Takaki A; Sone T; Ito S
Phys Med; 2016 Sep; 32(9):1180-5. PubMed ID: 27601249
[TBL] [Abstract][Full Text] [Related]
59. [Spinocerebellar degeneration and neuropeptides].
Matsuoka Y; Sakurai N
Nihon Naika Gakkai Zasshi; 1989 Dec; 78(12):1705-8. PubMed ID: 2516527
[No Abstract] [Full Text] [Related]
60. Changes in regional cerebral blood flow following antidepressant treatment in late-life depression.
Ishizaki J; Yamamoto H; Takahashi T; Takeda M; Yano M; Mimura M
Int J Geriatr Psychiatry; 2008 Aug; 23(8):805-11. PubMed ID: 18214999
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
